Biogen, Inc. (BIIB)
187.06
-2.22
(-1.17%)
USD |
NASDAQ |
May 01, 16:00
186.15
-0.91
(-0.49%)
After-Hours: 20:00
Biogen Free Cash Flow : 2.316B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
| Apellis Pharmaceuticals, Inc. | 45.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 645.50M |
| Cash from Investing (Quarterly) | -209.50M |
| Cash from Financing (Quarterly) | -43.80M |
| Free Cash Flow Per Share (Quarterly) | 3.769 |
| Free Cash Flow to Equity (Quarterly) | 655.00M |
| Free Cash Flow to Firm (Quarterly) | 616.48M |
| Free Cash Flow Yield | 8.41% |